Medication-info.com Search Menu

Cleocin Vaginal Suppository: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
100 mg
Active ingredient:

Patient information: uses, side effects, how to take - Cleocin Vaginal Suppository

DIRECTIONS FOR USE

How do I use CLEOCIN Vaginal Ovules?

For vaginal use only. Do not take by mouth.

Use one CLEOCIN Vaginal Ovule daily, preferably at bedtime, for 3 days in a row.

Do not use this product if the foiled pouches containing vaginal ovules are torn, opened, or incompletely sealed.

Read the full directions below before using.

Insertion without the applicator:

  1. 1. Remove the vaginal ovule from its packaging (See Figure 1).
  2. Figure 1
  3. 2. Holding the ovule with your thumb and a finger, insert it into the vagina (See Figure 2).
  4. Figure 2

  5. 3. Using your finger, gently push the ovule into the vagina as far as it will comfortably go (See Figure 3).
  6. Figure 3

  7. 4. Once inside the vagina, the ovule melts. Lie down as soon as possible. This will keep leakage to a minimum.
  8. 5. Repeat steps 1 through 4, before bedtime, for the next 2 days.

STORAGE CONDITIONS:

Store at 25°C (77°F); excursions permitted to 15 – 30°C (59 – 86°F) [see USP Controlled Room Temperature].

Caution: Avoid heat over 30°C (86°F). Avoid high humidity. See end of carton for the lot number and expiration date.

LAB-0649-4.0

Revised February 2026

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 050767 · View the label on DailyMed

Revision date stated in the text: February 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Cleocin Vaginal Suppository

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Lincosamide Antibacterial
Active ingredient Clindamycin phosphate 100 mg
Dosage form Suppository
Route Vaginal
Marketing status listed in the FDA NDC Directory
Company (applicant) PFIZER
FDA approval NDA 050767New Drug Application (NDA) Approved August 13, 1999
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
100 mg – 3 in 1 blister pack / 1 in 1 carton NDC 0009-7667-05

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.